A new survey from Health Union finds that people with relapsing forms of multiple sclerosis (MS) who currently use a disease-modifying therapy (DMT) report positive relationships with their healthcare professionals (HCP) and interest in prescription therapies, while those who have never used a DMT prefer alternative therapies and have experienced a less straight-forward MS journey than their counterparts.

Biologic therapies are a key area of focus in research in inflammatory bowel disease (IBD)--which includes Crohn’s disease and ulcerative colitis--that can be used to treat the disease by reducing inflammation, relieving symptoms, and helping the patient to enter and stay in remission. IBD In America 2019, a Health Union survey of 1,705 people living with a form of IBD, reveal there may be opportunities to help strengthen conversations about biologic therapies between people with IBD and their healthcare professionals (HCP).

Results from the qualitative analysis demonstrate that people with cancer are broadly misinformed about the benefits of palliative care and have some confusion around the timing and components of hospice care.